The Manhattan Regenerative Medicine Medical Group Announces an Adult Stem Cell Public Seminar in Rumson/Red Bank, New Jersey.
The Manhattan Regenerative Medicine Medical Group announces a free public seminar on the use of adult stem cells for various degenerative and inflammatory conditions. The seminar will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief and Dr. Nia Smyrniotis, Medical Director.
The seminar will be held on Friday, September 4, 2015 at 1:00 pm at the Molly Pitcher Inn, 88 Riverside Ave., Red Bank, NJ 07701. Please RSVP at (917) 410-7391, this event is by reservation only.
The Manhattan Regenerative Medicine Medical Group (Manhattan, New York), along with sister affiliates, the Miami Stem Cell Treatment Center (Miami; Boca Raton; Orlando; The Villages; Sarasota, Florida) and, the Irvine Stem Cell Treatment Center (Irvine; Westlake Village; Sacramento, California), abide by approved investigational protocols using adult adipose derived stem cells (ADSCs) which can be deployed to improve patients’ quality of life for a number of chronic, degenerative and inflammatory conditions and diseases. ADSCs are taken from the patient’s own adipose (fat) tissue (found within a cellular mixture called stromal vascular fraction (SVF)). ADSCs are exceptionally abundant in adipose tissue. The adipose tissue is obtained from the patient during a 15 minute mini-liposuction performed under local anesthesia in the doctor’s office. SVF is a protein-rich solution containing mononuclear cell lines (predominantly adult autologous mesenchymal stem cells), macrophage cells, endothelial cells, red blood cells, and important Growth Factors that facilitate the stem cell process and promote their activity.
ADSCs are the body’s natural healing cells – they are recruited by chemical signals emitted by damaged tissues to repair and regenerate the body’s injured cells. The Manhattan Regenerative Medicine Medical Group only uses Adult Autologous Stem Cells from a person’s own fat – No embryonic stem cells are used; and No bone marrow stem cells are used. Current areas of study include: Emphysema, COPD, Asthma, Heart Failure, Heart Attack, Parkinson’s Disease, Stroke, Traumatic Brain Injury, Lou Gehrig’s Disease, Multiple Sclerosis, Lupus, Rheumatoid Arthritis, Crohn’s Disease, Muscular Dystrophy, Inflammatory Myopathies, and degenerative orthopedic joint conditions (Knee, Shoulder, Hip, Spine). For more information, or if someone thinks they may be a candidate for one of the adult stem cell protocols offered by the Manhattan Regenerative Medicine Medical Group, they may contact Dr. Gionis or Dr. Smyrniotis directly at (917) 410-7391, or see a complete list of the Center’s study areas at: http://www.nystemcellsusa.com.
About the Manhattan Regenerative Medicine Medical Group: The Manhattan Regenerative Medicine Medical Group, along with sister affiliates, the Miami Stem Cell Treatment Center and the Irvine Stem Cell Treatment Center, is an affiliate of the California Stem Cell Treatment Center / Cell Surgical Network (CSN); we are located in Manhattan, New York. We provide care for people suffering from diseases that may be alleviated by access to adult stem cell based regenerative treatment. We utilize a fat transfer surgical technology to isolate and implant the patient’s own stem cells from a small quantity of fat harvested by a mini-liposuction on the same day. The investigational protocols utilized by the Manhattan Regenerative Medicine Medical Group have been reviewed and approved by an IRB (Institutional Review Board) which is registered with the U.S. Department of Health, Office of Human Research Protection (OHRP); and our studies are registered with Clinicaltrials.gov, a service of the U.S. National Institutes of Health (NIH). For more information, visit our websites: http://www.NYStemCellsUSA.com, http://www.MiamiStemCellsUSA.com,http://www.IrvineStemCellsUSA.com, or http://www.TheStemCellShow.com.